Researchers are beginning to wonder if blockbuster drugs like Wegovy, Ozempic and Zepbound could play a role in preventing ...

Widely used GLP-1 drugs for type 2 diabetes such as Novo Nordisk's Ozempic may modestly reduce the risk of obesity-related ...

An Ozempic Expert Explains What You Need to Know ... finding a difference and others not finding a difference in cancer risk—seemed to come from the fact that some studies do what we did ...

Mounjaro, Ozempic and other fat-melting injections ... no medications have been proven to lower the cancer risk associated with obesity. 'Our study begins to fill that gap by evaluating GLP ...

Researchers found GLP-1s may modestly reduce the risk of 14 obesity-related cancers, especially colorectal cancer, when ...

Weight-loss drugs and bariatric surgery both have an impact on cancer risk. A new study breaks down the link and how GLP-1 ...

Saxenda and Ozempic have a boxed warning for risk of thyroid cancer. A boxed warning is a serious warning from the FDA. To learn more, see the “Precautions for Saxenda and Ozempic” section.

An international study reveals that the drug can reverse liver damage in patients. An international study led by researchers ...

Based on animal studies, it’s thought that Ozempic may increase your risk of thyroid cancer. It’s important to note that animal studies don’t always predict what will happen in humans.

Excess body weight can raise the risk of certain cancers, leading researchers to wonder whether blockbuster drugs like Wegovy, Ozempic and Zepbound could play a role in cancer prevention.

Weight loss jabs could reduce the risk of up to 14 types of cancer, new research has found. Mounjaro, Ozempic and other ...

In the wake of early evidence supporting the long-term health benefits of GLP-1 based medications to potentially reduce the ...